CaseBioscience Unites ART with CGT
October 2024 – CaseBioscience is pioneering a transformative approach to biotechnology by merging the clinical success of Assisted Reproductive Technology (ART) with advancements in Cell & Gene Therapy (CGT). This innovative platform integrates decades of expertise in both fields to create groundbreaking culture media and biosolutions that address key challenges in ART and CGT.
